Objectives: Various diagnostic techniques have been evolved over the periods to determine the etiology of abnormal uterine bleeding in peri-menopausal women, but their accuracy has not been compared properly. In this study diagnostic accuracy of trans-vaginal sonography (TVS), saline infusion sonography (SIS) and dilatation & curettage (D & C) were compared with hysteroscopic guided biopsy to determine the etiology. Methods: In this study, 252 patients had to undergo trans-vaginal sonography and saline infusion sonography in the same sitting followed by hysteroscopic-guided biopsy and dilatation and curettage. All the materials were sent for histopathological examination. Results: In determining uterine pathology, positive likelihood ratio (PLR) of TVS, SIS and D & C are 2.81, 7.5 and 3.81 respectively considering hysteroscopy as standard. Conclusion: Sensitivity of SIS as a test for detecting pathology in abnormal uterine bleeding (AUB) is high and can be easily performed on out patient basis. D&C has a very low sensitivity and is unacceptable as a screening test for the same conditions.
Introduction:
Abnormal uterine bleeding (AUB) in peri-menopausal age group is a common but ill-defined entity which needs proper evaluation. Goldstein et al 1 has defined AUB as "Patients having either metrorrhagia defined as vaginal bleeding separated from expected menses or menorrhagia defined as patients' subjective complaints of either increased duration or increased volume of flow or both". In general, women present themselves to the gynaecologists whenever there is a departure from their personal menstrual experiences. Variations from the normal cyclical pattern in the peri-menopausal age may be due to physiological hormonal changes on one hand or may be due to neoplastic changes either benign or malignant, on the other hand. Therefore, accurate diagnosis of the causative factor of AUB in this age group is of utmost importance so that appropriate management can be established. Tests with AUB. Hysteroscopy guided biopsy was taken as the standard in this study. Hysterectomy and histopathological examination of the entire uterus would provide a more accurate diagnosis but this procedure is neither desirable nor ethical to perform in all perimenopausal patients with AUB.
Methods:
From September 2005 to January 2008, 274 patients of rural Bengal, belonging to the age group 40 to 50 years attending the gynecology out patient department with abnormal uterine bleeding (AUB) of at least three months duration, were included in this prospective study. 
Results and analysis:
Complete data was available on 252 patients and the findings have been shown in (Table 2 ).
Considering the findings of hysteroscopy guided biopsy as reference, sensitivity, specificity and likelihood ratio for the different methods were calculated. Likelihood ratio (LHR) represents the ratio of the likelihood of a positive (or negative) test result with pathology to the likelihood of the same test result in those without pathology 3 . In the present study, TVS had a sensitivity of 86.4 % and positive likelihood ratio (PLR) of 2.81, while SIS had a much higher sensitivity and PLR of 90.6 % and 7.5 respectively. D & C had a very low sensitivity albeit a high specificity of 61 % and 84 % respectively and a PLR of 3.81. Specificity of D & C was high as it was more likely to miss a pathology in its presence than diagnose one in its absence. Sensitivity, specificity and likelihood ratios for detection of polyp, fibroid and abnormal uterine pathology by each test are outlined in Table 3 . 
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Discussion:
Peri-menopause includes the period beginning with the first clinical, biological and endocrinological features of the approaching menopause and ending twelve months after the last menstrual period. Accurate diagnosis of the cause of AUB in perimenopausal age group is critical. An ideal diagnostic test should be non or minimally invasive, easy to perform, easily acceptable to the patients, low cost and of high sensitivity and specificity. Unfortunately none of the diagnostic tests evolved so far, has fulfilled all the required criteria. Pipple's endometrial sampling and Vabra aspirator initially gained popularity as they were easy to perform, but they lack specificity for focal pathology with unacceptable false negative rates 4 . D & C also is being gradually discarded as a modern day procedure because of its low diagnostic reliability and unacceptable complications 5 . Meta-analysis has demonstrated that sonographic measurement of endometrial thickness is an acceptable test for prediction of endometrial pathology, but it has its limitation in correctly diagnosing the type of endometrial pathology 6 . Minimum endometrial thickness considered to be abnormal was accepted as 5 mm in the present study as it is well proved that the risk of endometrial malignancy in patients with post-menopausal bleeding and with an endometrial thickness <=4 mm is less than 1%
7
.
Imaging studies for AUB are commonly done but no previous study has tried to define the ability of SIS or TVS in detecting different endometrial pathologies in comparison to a standard procedure like hysteroscopyguided biopsy. Performing a hysterectomy and histopathological examination of the resected uterus would be an ideal reference standard but as this is not always possible in perimenopausal patients on ethical ground and at the same time is unacceptable to the patients, we have selected hysteroscopic biopsy as the reference standard for comparing the other tests viz. TVS, SIS and D&C.
Vercellini et al
8 evaluated the role of transvaginal ultrasonography and diagnostic hysteroscopy in premenopausal menorrhagic patients irrespective of their age. In the 40 to 50 years age group of their study population, hysteroscopy was able to diagnose polyp and fibroid in 23.5 % and 14 % of the women respectively and was negative in 53.8% of the cases. In the present study, the corresponding figures were 12.4%, 18.1% and 38.9% respectively. However, it should be remembered that their patient population was 'premenopausal menorrhagic' while our patients were 'perimenopausal with AUB'. Similarly, in their study, 39% of the overall patients were normal in TVS and sensitivity & specificity of TVS was 96% and 86% respectively; whereas, the comparative figures are 35.7 %, 86% and 69% respectively in our study. The incidence of polyp in patients with AUB in Allameh et al 9 series was 38 % and that of Laifer-Narin et al 10 was 42 %. Both were surprisingly high in comparison to our findings and are probably due to difference in patient selection. Goldstein et al 1 have done SIS followed by D&C and / or hysteroscopy only in those cases with abnormal TVS finding which do not allow a proper comparison between the tests.
Not a single incidence of endometrial malignancy has been found in the present study. Apparently it seems to be astonishing but if we consider the demographic pattern of the participating women, most of whom are coming from the low socio-economic class where obesity and hypertension are rare, 'hormone replacement therapy' unheard of and 88.5% were multipara, then it will appear as a logical phenomenon. So was the result of the study by Allameh et al 9 .
The criteria that distinguish a definitely useful clinical test from one that is of doubtful value has been shifted from the older concept of sensitivity and specificity to the newer and more powerful concept of 'Likelihood Ratios' (LRs 11 . In the present study, with a positive LR value of 7.5 and a negative LR value of 0.1, SIS has turned out to be a moderately good test for detecting uterine pathology as well as for screening purposes that need further evaluation. Both TVS and D&C have low positive LR values (2.81 & 3.81 respectively) and are unacceptable as diagnostic test for uterine pathology. TVS has slightly higher false positive rate (Type-II error) while D&C has high false negative rate (Type-I error). With a low negative LR value (0.2), TVS may be considered as a screening test only, in which aspect also D&C (negative LR value of 0.46) is an unaccepted one. In detecting anatomical abnormalities like polyp or fibroid, none of the imaging studies appeared to be superior to hysteroscopy.
Another problem of the radiologists arises when they have to diagnose the exact form of hyperplasia as it can be established by pathological examination only. Hysteroscopy offers the possibility of visualizing macroscopic or focal abnormalities suggestive of endometrial hyperplasia and of taking biopsy under visual control known as 'targeted hysteroscopic biopsy'. But the lack of established hysteroscopic criteria for 'abnormal endometrial hyperplasia' and it's overlapping pattern with the normal late secretory endometrium, mainly in pre-menopausal women, is a limitation that still arouses some doubt to the reliability of this procedure 12 . Another problem of hysteroscopy is that it needs specialized equipment, skilled operator and general anaesthesia or when performed as an office procedure with local or no anesthesia, it can cause significant patient discomfort. Chambers 13 commented, "The expense and time involved in the use of hysteroscope are not justified for routine evaluation of all the women with abnormal uterine bleeding".
The concluding remark of Vercellini et al 8 is remarkable in this aspect "Considering the good specificity and negative predictive value, TVS may be suggested as the initial investigation in pre-menopausal patients with menorrhagia. When appropriate, endometrial biopsy may be performed. Hysteroscopy may be limited to cases with a positive or doubtful TVS finding with the aim of defining the lesion, obtaining targeted biopsy and evaluating endoscopic operability correctly". We only like to replace 'TVS' with 'SIS' in 'peri-menopausal patients with AUB' keeping the role of hysteroscopy unaltered as suggested by Vercellini et al 8 .
Conclusion:
From the present study, it is clear that accuracy of SIS as a test for detecting pathology in AUB in perimenopausal patients is moderately good and suitable for developing countries whereas D&C is unacceptable as a screening test. However, hysteroscopy and guided biopsy if can be performed as office procedure, still is the tool of choice both for screening as well as diagnostic purposes.
